$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
利妥昔单抗的治疗效果如何?常见的不良反应有哪些
2025-10-19 11:44:20
Check Details
百时美施贵宝的Breyanzi和吉利德的Yescarta在早期淋巴瘤治疗中势均力敌
2025-10-19 11:44:20
Check Details
Yescarta®一线治疗高危大B细胞淋巴瘤,完全缓解率可达78%!
2025-10-19 11:44:20
Check Details
Yescarta®对非霍奇金淋巴瘤成人患者显示出两年的持久临床疗效
2025-10-19 11:44:20
Check Details
Kymriah®治疗复发或难治性滤泡性淋巴瘤高风险患者疗效强大
2025-10-19 11:44:20
Check Details
第一三共公司授权日本第一家YESCARTA® CAR-T细胞治疗中心
2025-10-19 11:44:20
Check Details
Pirtobrutinib在1/2期临床试验中显示出持久的疾病控制
2025-10-19 11:44:20
Check Details
Parsaclisib治疗数据更新:复发或难治性B细胞非霍奇金淋巴瘤患者可产生快速且持久的缓解
2025-10-19 11:44:20
Check Details
在南京可以买到杜韦利西布吗?多少钱?
2025-10-19 11:44:20
Check Details
YTB323治疗复发/难治性DLBCL显示出良好的有效性和安全性
2025-10-19 11:44:20
Check Details
2021年套细胞淋巴瘤治疗取得了哪些进展?
2025-10-19 11:44:20
Check Details
苯达莫司汀的疗效好吗?长期用苯达莫司汀会有哪些副作用
2025-10-19 11:44:20
Check Details
1
2
...
1257
1258
1259
1260
1261
1262
1263
...
4150
4151
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
2
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
3
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
4
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
5
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
6
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
7
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
8
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
9
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
10
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
11
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
12
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).